Engineered from two algae-derived polysaccharides, TraumaGel is injected directly into severe lacerations and bullet wounds to stop life-threatening hemorrhages on contact. Today, Cresilon operates as the only bio-manufacturing facility in New York City, with over 100 employees and its products are deployed in more than 250 national trauma systems.

Cofounder and CEO Joe Landolina breaks down the journey from a college dorm room concept to an FDA-cleared device transforming emergency trauma response.